Skip to main content
SpringerLink
Log in

Ulcerative Colitis

History of a Successful Treatment

  • Case Report
  • Published:
BioDrugs Aims and scope Submit manuscript

Abstract

In this report we describe a case of a 19-year-old woman with a severe to fulminant steroid-resistant ulcerative colitis that was successfully treated with infliximab. Severe to fulminant ulcerative colitis is a potentially life-threatening condition and although the mortality rate has dropped dramatically over the past 40 years, this has not been the case with colectomy which has remained unchanged. Recently, infliximab has been shown to be effective as rescue therapy for steroid-refractory cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1983; 85: 351–7

    Google Scholar 

  2. Meyers S, Lerer PK, Feuer EJ, et al. Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol 1987; 9: 50–4

    Article  PubMed  CAS  Google Scholar 

  3. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to sterid therapy. N Engl J Med 1994; 30-330: 1841–5

    Article  Google Scholar 

  4. Carter MU, Lobo AJ, Travis SP. IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53: V1–16

    Article  PubMed  Google Scholar 

  5. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985; 89: 1005–13

    PubMed  CAS  Google Scholar 

  6. McIntyre DB, Powell-Tuck J, Wood SR. Controlled trial of bowel rest in the treatment of severe active colitis. Gastroenterology 1980; 79: 1199–204

    Google Scholar 

  7. Rutgeerts P, Sanndborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 8-353: 2462–76

    Article  Google Scholar 

  8. Sands BE, Tremaine WJ, Sandborn Wj, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001; 7: 83–7

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Dr Lago received honoraria for the submission of the case report, which was funded by Schering-Plough/MSD Portugal.

Author information

Authors and Affiliations

  1. Gastroenterology Department, Centro Hospitalar do Porto-Hospital de Santo António, Porto Largo do Prof. Abel, Salazar, 4050-371, Porto, Portugal

    Paula Lago

Authors
  1. Paula Lago
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paula Lago.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lago, P. Ulcerative Colitis. BioDrugs 24 (Suppl 1), 34–36 (2010). https://doi.org/10.2165/11586230-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11586230-000000000-00000

Keywords

Search

Navigation